BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein
Frontiers in Immunology
Open Access Publication
Rights and Permissions
Manangeeswaran M, Ireland DDC, Thacker SG, Lee H-N, Kelley-Baker L, Lewkowicz AP, Rothlauf PW, Cornejo Pontelli M, Bloyet L-M, Eckhaus MA, Mendoza MI, Whelan S and Verthelyi D (2022) BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein. Front. Immunol. 13:919815. doi: 10.3389/fimmu.2022.919815 © 2022 Manangeeswaran, Ireland, Thacker, Lee, Kelley-Baker, Lewkowicz, Rothlauf, Cornejo Pontelli, Bloyet, Eckhaus, Mendoza, Whelan and Verthelyi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Manangeeswaran, Mohanraj; Ireland, Derek D C; Thacker, Seth G; Lee, Ha-Na; Kelley-Baker, Logan; Lewkowicz, Aaron P; Rothlauf, Paul W; Cornejo Pontelli, Marjorie; Bloyet, Louis-Marie; Eckhaus, Michael A; Mendoza, Mirian I; Whelan, Sean; and Verthelyi, Daniela, "BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein." Frontiers in Immunology. 13, 919815 (2022).